Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0HQVXQ
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
TORL-3-600
|
|||||
| Synonyms |
TORL-3-600-ADC; TORL-3-600 ADC
Click to Show/Hide
|
|||||
| Organization |
TORL Biotherapeutics LLC; Translational Research In Oncology US, Inc.
|
|||||
| Drug Status |
Phase 1
|
|||||
| Indication |
In total 1 Indication(s)
Colorectal cancer [ICD11:2B91]
Phase 1
|
|||||
| Antibody Name |
Undisclosed
|
Antigen Name |
Undisclosed
|
|||
| Payload Name |
Undisclosed
|
|||||
| Linker Name |
Undisclosed
|
|||||
If you find any error in data or bug in web service, please kindly report it to Dr. Shen et al.